Status:
COMPLETED
Resveratrol for Patients With Colon Cancer
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
University of California, Los Angeles
Conditions:
Colon Cancer
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Resveratrol is purported to possess cancer preventive activity, especially for colon cancer, though its mechanisms of action are not well defined. Resveratrol is found in the skin of grapes and has an...
Detailed Description
Patients will be treated with a two-week course of resveratrol. The initiation of the treatment will be approximately 14 days before standard of care surgical resection of tumor. Resveratrol will be i...
Eligibility Criteria
Inclusion
- Patients diagnosed with colon cancer by colonoscopic biopsy and tissue obtained under UCI04-05.
- Patients with a plan for surgical resection at UCIMC within 2-4 weeks of enrollment.
Exclusion
- Surgical resection to be performed at a facility other than UCIMC.
- Patients under 18 years of age.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00256334
Start Date
July 1 2005
End Date
April 1 2009
Last Update
June 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chao Family Comprehensive Cancer Center
Orange, California, United States, 92868